Clinical trial / 2009
Regular sunscreen use may prevent actinic keratoses and invasive squamous cell carcinomas in organ transplant recipients.
A 24-month prospective study evaluated 120 matched organ transplant recipients where 60 patients received free broad-spectrum sunscreen (SPF>50) for daily application alongside standard sun protection advice given to all participants. Over 24 months, 8 new invasive SCCs occurred in the control group versus 0 in the sunscreen group (P<0.01), and new AK counts differed significantly (-102 in sunscreen group vs. +82 in controls; P<0.01). BCC occurrences were 2 in the sunscreen group versus 9 in controls (not significant). Serum 25(OH)D levels were lower in the sunscreen group than controls (mean 53 ng mL(-1) vs. 60 ng mL(-1)).
- Study type
- Prospective, matched controlled study
- Who was studied
- 120 matched organ transplant recipients (40 heart, 40 kidney, 40 liver)
- What was measured
- New actinic keratoses (AK), invasive squamous cell carcinomas (SCC), basal cell carcinomas (BCC), and serum 25(OH)D levels
THE PAPER
Prevention of non-melanoma skin cancer in organ transplant patients by regular use of a sunscreen: a 24 months, prospective, case-control study.
Ulrich C, Jürgensen JS, Degen A, Hackethal M, Ulrich M, Patel MJ, Eberle J, Terhorst D, Sterry W, Stockfleth E. Br J Dermatol, 2009.
This note is written from the study's published abstract. It summarizes what the authors reported; it is not medical advice and does not replace reading the full paper.